1. Home
  2. STELLA PHARMA NEWS
  3. Information
STELLA PHARMA NEWS
Information
November 20th, 2024

Paper published: Research on Combination of Proton Beam Therapy and Boron Nuclear Capture Reaction

The Paper titled “Increased cell killing effect in neutron capture enhanced pro……

READ MORE

September 6th, 2024

Conclusion of an Agreement with the National Cancer Center, Sumitomo Heavy Industries, Ltd. and CICS, Inc. for Clinical Trial of BNCT

Stella Pharma announces that it has signed an agreement with the National Cance……

READ MORE

August 30th, 2024

Paper published: Research on Combination Therapy of BNCT and Immune Checkpoint Inhibitors

The Paper “Overcoming immunotherapy resistance and inducing abscopal effects wi……

READ MORE

August 30th, 2024

Application for Orphan Drug Designation: Borofalan (10B) for Recurrent Malignant Glioma and Recurrent Meningioma

Stella Pharma announces that it has applied to the Japanese Ministry of Health,……

READ MORE

July 10th, 2024

Safety and Efficacy of BNCT: paper in “Radiotherapy and Oncology” 

The paper “Efficacy and safety of boron neutron capture therapy for Hypopharyng……

READ MORE

June 21st, 2024

Treatment results of unresectable, locally recurrent or locally advanced head and neck cancer published

A paper containing the treatment results of unresectable, locally recurrent or ……

READ MORE

December 25th, 2023

Orphan Drug designation for Borofalan (10B) (SPM-011) as treatment of Cutaneous Angiosarcoma

Angiosarcoma is a kind of cancer that is derived from vascular endothelial cell……

READ MORE

December 6th, 2023

Encounter with Director of Cancer Research Center of Lyon, and Team of Centre Léon Bérard at French Embassy

Business France Japan Office of the French Embassy in Japan engages in building……

READ MORE

September 29th, 2022

Groundbreaking Ceremony for the Hainan BNCT Center

On 25th September, the Groundbreaking Ceremony for the Boao BNCT center has tak……

READ MORE

September 27th, 2022

Stella Pharma Presented at Side Events of the 66th IAEA General Conference

The 66th International Atomic Energy Agency (IAEA) General Conference is being ……

READ MORE

April 7th, 2022

Stella Pharma Corporation was nominated as a finalist of the Informa Pharma Intelligence Awards Japan 2022

Informa Pharma Intelligence has announced that Stella Pharma is a nominee f……

READ MORE

February 18th, 2022

“Destroying Cancer with Boron and Neutrons” will be on NHK WORLD-JAPAN

Japan's public media organization NHK (Japan Broadcasting Corporation) will bro……

READ MORE